Literature DB >> 3525975

[Factors interfering with the dexamethasone suppression test].

R Liebl.   

Abstract

The interpretation of the dexamethasone suppression test in endocrinology and psychiatry depends on several variables. False-positive results can be caused by stress, weight loss, alcohol withdrawal, treatment with diphenylhydantoin, phenobarbital, rifampicin, carbamazepine and lithium. Therapy with spironolactone, naloxone, alpha 1-mimetic agents and estrogen can be responsible for an increase in plasma-cortisol concentration. False-negative results are seen in patients with liver disease and can also result from therapy with benzodiazepines at high dosages, indomethacin and possibly methadone and ketoconazole.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3525975     DOI: 10.1007/bf01735315

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  53 in total

1.  Effect of diphenylhydantoin on cortisol kinetics in humans.

Authors:  Y Choi; K Thrasher; E E Werk; L J Sholiton; C Olinger
Journal:  J Pharmacol Exp Ther       Date:  1971-01       Impact factor: 4.030

2.  Effect of the anticholinergic drug biperiden on pituitary hormones and cortisol.

Authors:  O Benkert; H E Klein; E Hofschuster; C Seibold
Journal:  Psychoneuroendocrinology       Date:  1981       Impact factor: 4.905

3.  Interference by carbamazepine with the dexamethasone suppression test.

Authors:  M R Privitera; J F Greden; R W Gardner; J C Ritchie; B J Carroll
Journal:  Biol Psychiatry       Date:  1982-05       Impact factor: 13.382

4.  The effects of circumcision on serum cortisol and behavior.

Authors:  M R Gunnar; R O Fisch; S Korsvik; J M Donhowe
Journal:  Psychoneuroendocrinology       Date:  1981       Impact factor: 4.905

5.  Serum cortisol response to incremental work in experienced and naive subjects.

Authors:  H A Davis; G C Gass; J R Bassett
Journal:  Psychosom Med       Date:  1981-04       Impact factor: 4.312

6.  Endocrine complications of topical and intralesional corticosteroid therapy.

Authors:  J A Curtis; E Cormode; B Laski; J Toole; N Howard
Journal:  Arch Dis Child       Date:  1982-03       Impact factor: 3.791

7.  Cushing's disease with 'normal suppression' due to decreased dexamethasone clearance.

Authors:  L P Kapcala; S M Hamilton; A W Meikle
Journal:  Arch Intern Med       Date:  1984-03

8.  The dexamethasone suppression test in panic disorder and agoraphobia.

Authors:  G C Curtis; O G Cameron; R M Nesse
Journal:  Am J Psychiatry       Date:  1982-08       Impact factor: 18.112

9.  Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype?

Authors:  M Berger; P Doerr; R Lund; T Bronisch; D von Zerssen
Journal:  Biol Psychiatry       Date:  1982-11       Impact factor: 13.382

10.  Plasma corticosteroid concentrations during spironolactone administration: evidence for adrenal biosynthetic blockade in man.

Authors:  M L Tuck; J R Sowers; D B Fittingoff; J S Fisher; G J Berg; N D Asp; D M Mayes
Journal:  J Clin Endocrinol Metab       Date:  1981-06       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.